Bank of New York Mellon
LYRA

Bank of New York Mellon’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Bank of New York Mellon’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,432
Closed -$9.04K – 4213
2025
Q1 		$9.04K Sell
1,432
-87
-6% -$814 ﹤0.01% 4103
2024
Q4 		$15.7K Hold
1,519
– – ﹤0.01% 4105
2024
Q3 		$19.5K Sell
1,519
-29
-2% -$426 ﹤0.01% 4072
2024
Q2 		$21.4K Buy
+1,548
New +$175K ﹤0.01% 4080
2024
Q1 		– Sell
-372
Closed -$97.6K – 4253
2023
Q4 		$97.6K Hold
372
– – ﹤0.01% 4088
2023
Q3 		$72.8K Buy
+372
New +$66.5K ﹤0.01% 4128
2022
Q4 		– Sell
-390
Closed -$98K – 4525
2022
Q3 		$98K Buy
+390
New +$115K ﹤0.01% 4200
2021
Q2 		– Sell
-301
Closed -$174K – 4436
2021
Q1 		$174K Sell
301
-88
-23% -$55K ﹤0.01% 4089
2020
Q4 		$222K Buy
389
+76
+24% +$42.8K ﹤0.01% 3944
2020
Q3 		$175K Buy
313
+48
+18% +$29.8K ﹤0.01% 3874
2020
Q2 		$151K Buy
+265
New +$194K ﹤0.01% 3859

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon's LYRA Position: Q2 2025 in Review

Bank of New York Mellon sold out of LYRA THERAPEUTICS INC (LYRA) in Q2 2025, closing a stake of 1,432 shares — an estimated $9.04K sold.

Bank of New York Mellon first reported a position in LYRA in Q2 2020 and held it in 11 quarters. The position peaked at $222K in Q4 2020. 30 funds tracked by Wall St. Rank hold LYRA as of Q2 2025.

  • Bank of New York Mellon reported no remaining LYRA THERAPEUTICS INC position as of Q2 2025 after selling out during the quarter.
  • Bank of New York Mellon sold 1,432 LYRA THERAPEUTICS INC shares in Q2 2025, an estimated $9.04K.
  • Bank of New York Mellon first reported a position in LYRA THERAPEUTICS INC in Q2 2020 and held it in 11 quarters.
  • Bank of New York Mellon's LYRA THERAPEUTICS INC position peaked at $222K in Q4 2020.
  • 30 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q2 2025.

Based on Bank of New York Mellon's 13F filing for Q2 2025, filed 5 Aug 2025.